Literature DB >> 15052663

Spatiotemporal analysis of programmed cell death during mouse cardiac septation.

Pundrique R Sharma1, Robert H Anderson, Andrew J Copp, Deborah J Henderson.   

Abstract

Cell death is thought to play an important role in mammalian cardiogenesis, although a precise map of its distribution during the crucial period of cardiac septation has so far been lacking. In this study, the spatiotemporal distribution of programmed cell death (PCD) during mouse cardiac septation is described between embryonic days 10.5 and 13.5. Two types of foci of cell death can be demonstrated in the developing heart. Those with high-intensity, with a PCD index greater than 1%, are clearly visible on individual TUNEL-assayed sections. Low-intensity foci, with a PCD index of less than 1%, become visible only following summation of data. High-intensity foci occur exclusively within the endocardial cushions of the outflow tract and atrioventricular region, appearing at the 52-54 somite stage (late E11.5), concomitant with the formation of the central mesenchymal mass. Low-intensity foci are present throughout the period of cardiac development from E10.5 to E13.5 and are frequently localized to regions of septation, such as the muscular ventricular septum and the mesenchymal cap of the primary atrial septum. Expression of Fas and FasL corresponds to these low-intensity foci, but not those with high-intensity, suggesting that activation of this death receptor may be specifically involved in molecular control of the low-intensity foci. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15052663     DOI: 10.1002/ar.a.20006

Source DB:  PubMed          Journal:  Anat Rec A Discov Mol Cell Evol Biol        ISSN: 1552-4884


  8 in total

1.  miRNA-processing enzyme Dicer is necessary for cardiac outflow tract alignment and chamber septation.

Authors:  Ankur Saxena; Clifford J Tabin
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-14       Impact factor: 11.205

2.  Impaired clearance of apoptotic cardiocytes is linked to anti-SSA/Ro and -SSB/La antibodies in the pathogenesis of congenital heart block.

Authors:  Robert M Clancy; Petra J Neufing; Ping Zheng; Marguerita O'Mahony; Falk Nimmerjahn; Tom P Gordon; Jill P Buyon
Journal:  J Clin Invest       Date:  2006-08-10       Impact factor: 14.808

3.  A threshold of GATA4 and GATA6 expression is required for cardiovascular development.

Authors:  Mei Xin; Christopher A Davis; Jeffery D Molkentin; Ching-Ling Lien; Stephen A Duncan; James A Richardson; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-17       Impact factor: 11.205

4.  Neural crest-derived SEMA3C activates endothelial NRP1 for cardiac outflow tract septation.

Authors:  Alice Plein; Amélie Calmont; Alessandro Fantin; Laura Denti; Naomi A Anderson; Peter J Scambler; Christiana Ruhrberg
Journal:  J Clin Invest       Date:  2015-06-08       Impact factor: 14.808

5.  Cell senescence, apoptosis and DNA damage cooperate in the remodeling processes accounting for heart morphogenesis.

Authors:  Carlos I Lorda-Diez; Michelle E Solis-Mancilla; Cristina Sanchez-Fernandez; Juan A Garcia-Porrero; Juan M Hurle; Juan A Montero
Journal:  J Anat       Date:  2019-03-15       Impact factor: 2.610

6.  Foregut separation and tracheo-oesophageal malformations: the role of tracheal outgrowth, dorso-ventral patterning and programmed cell death.

Authors:  Adonis S Ioannides; Valentina Massa; Elisabetta Ferraro; Francesco Cecconi; Lewis Spitz; Deborah J Henderson; Andrew J Copp
Journal:  Dev Biol       Date:  2009-11-10       Impact factor: 3.582

7.  A pictorial account of the human embryonic heart between 3.5 and 8 weeks of development.

Authors:  Jill P J M Hikspoors; Nutmethee Kruepunga; Greet M C Mommen; S Eleonore Köhler; Robert H Anderson; Wouter H Lamers
Journal:  Commun Biol       Date:  2022-03-11

Review 8.  New Concepts in the Development and Malformation of the Arterial Valves.

Authors:  Deborah J Henderson; Lorraine Eley; Bill Chaudhry
Journal:  J Cardiovasc Dev Dis       Date:  2020-09-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.